Vitolo, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.225
AS - Asia 7.388
EU - Europa 4.150
SA - Sud America 1.141
OC - Oceania 262
Continente sconosciuto - Info sul continente non disponibili 206
AF - Africa 147
Totale 23.519
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.932
SG - Singapore 2.255
CN - Cina 2.033
IT - Italia 1.515
HK - Hong Kong 998
BR - Brasile 908
VN - Vietnam 683
GB - Regno Unito 559
FI - Finlandia 449
BD - Bangladesh 364
SE - Svezia 364
DE - Germania 314
KR - Corea 310
AU - Australia 255
RU - Federazione Russa 247
FR - Francia 190
CA - Canada 143
ID - Indonesia 133
IN - India 127
AR - Argentina 86
NL - Olanda 78
MX - Messico 68
BG - Bulgaria 60
IQ - Iraq 58
JP - Giappone 56
TR - Turchia 55
AE - Emirati Arabi Uniti 52
PL - Polonia 45
ZA - Sudafrica 45
AT - Austria 43
UA - Ucraina 42
ES - Italia 41
PK - Pakistan 41
CO - Colombia 37
EC - Ecuador 36
LT - Lituania 35
UZ - Uzbekistan 30
IE - Irlanda 29
MA - Marocco 25
VE - Venezuela 24
MY - Malesia 23
KE - Kenya 20
SA - Arabia Saudita 19
EG - Egitto 18
TH - Thailandia 18
AZ - Azerbaigian 16
CL - Cile 16
RS - Serbia 16
BE - Belgio 14
CH - Svizzera 13
CZ - Repubblica Ceca 13
JO - Giordania 13
PH - Filippine 13
NP - Nepal 12
OM - Oman 12
RO - Romania 12
TN - Tunisia 12
TW - Taiwan 12
AL - Albania 11
BO - Bolivia 10
GT - Guatemala 10
PY - Paraguay 10
DZ - Algeria 9
JM - Giamaica 9
KZ - Kazakistan 9
TT - Trinidad e Tobago 9
CR - Costa Rica 8
PE - Perù 8
SV - El Salvador 8
IL - Israele 7
NZ - Nuova Zelanda 7
HU - Ungheria 6
NI - Nicaragua 6
PT - Portogallo 6
BA - Bosnia-Erzegovina 5
BY - Bielorussia 5
CU - Cuba 5
DO - Repubblica Dominicana 5
GE - Georgia 5
HN - Honduras 5
KG - Kirghizistan 5
LU - Lussemburgo 5
LV - Lettonia 5
NG - Nigeria 5
UY - Uruguay 5
CY - Cipro 4
EE - Estonia 4
HR - Croazia 4
IR - Iran 4
PA - Panama 4
SK - Slovacchia (Repubblica Slovacca) 4
BN - Brunei Darussalam 3
DK - Danimarca 3
ET - Etiopia 3
LB - Libano 3
LK - Sri Lanka 3
MT - Malta 3
NO - Norvegia 3
SI - Slovenia 3
SN - Senegal 3
Totale 23.276
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.515
Singapore 1.409
Ashburn 1.164
Hong Kong 988
Hefei 891
San Jose 802
Chandler 427
Council Bluffs 411
Fairfield 396
Helsinki 390
London 321
Seoul 304
Beijing 285
Nyköping 283
The Dalles 270
Los Angeles 264
New York 248
Ho Chi Minh City 223
Houston 178
Woodbridge 169
Perth 167
Milan 165
Seattle 162
Hanoi 152
Wilmington 141
Chicago 133
Cambridge 129
Bologna 124
Buffalo 113
Dallas 110
Rome 109
San Diego 106
Jakarta 103
Munich 98
Modena 95
São Paulo 93
Lauterbourg 79
Shanghai 79
Princeton 69
Ann Arbor 67
Moscow 63
Southend 63
Sofia 56
Salt Lake City 53
Kent 50
Columbus 47
Toronto 44
Da Nang 43
Sydney 42
Boardman 41
Frankfurt am Main 41
Tokyo 40
Montreal 39
Orem 37
Lappeenranta 36
Johannesburg 34
Atlanta 32
Nuremberg 32
Naples 30
Denver 29
Dublin 29
Haiphong 28
Tashkent 28
Amsterdam 27
Mexico City 27
Redondo Beach 27
Kilburn 26
Rio de Janeiro 25
Warsaw 25
Guangzhou 24
Memphis 24
Brooklyn 23
Parma 23
Phoenix 23
Turin 23
Chennai 22
Lakewood 22
Reggio Emilia 22
Turku 22
Schiffdorf 21
Baghdad 20
Boston 20
Elk Grove Village 20
Jacksonville 20
Miami 20
Tampa 20
Biên Hòa 19
North Bergen 19
Stockholm 19
Vienna 19
Belo Horizonte 18
Campinas 17
Mumbai 17
Paris 17
Portsmouth 17
Dubai 16
Miano 16
Perugia 16
Quito 16
Düsseldorf 15
Totale 14.936
Salva come PNG Salva come JPEG
Nome #
Atrial Fibrillation in the Setting of Acute Pneumonia: Not a Secondary Arrhythmia 505
Radar-Based Monitoring of Vital Signs: A Tutorial Overview 355
Ibrutinib and Bruton's tyrosine kinase inhibitors in chronic lymphocytic leukemia: focus on atrial fibrillation and ventricular tachyarrhythmias/sudden cardiac death 342
Oral anticoagulants in patients with atrial fibrillation and end-stage renal disease: Walking the tightrope between thromboembolic and bleeding risk 324
Cardiolaminopathies from bench to bedside: challenges in clinical decision-making with focus on arrhythmia-related outcomes 311
Percutaneous pericardiocentesis for pericardial effusion: predictors of mortality and outcomes 306
Device-detected atrial high rate episodes and the risk of stroke/thrombo-embolism and atrial fibrillation incidence: a systematic review and meta-analysis 305
DIGItal Health Literacy after COVID-19 Outbreak among Frail and Non-Frail Cardiology Patients: The DIGI-COVID Study 284
Asymptomatic vs. symptomatic atrial fibrillation: Clinical outcomes in heart failure patients 282
The role of physical activity in individuals with cardiovascular risk factors: an opinion paper from Italian Society of Cardiology-Emilia Romagna-Marche and SIC-Sport 263
Cardioversion of recent-onset atrial fibrillation: current evidence, practical considerations, and controversies in a complex clinical scenario 262
The 2024 ESC guidelines on atrial fibrillation: essential updates for everyday clinical practice 260
2022 ESC Guidelines for the management of ventricular arrhythmias and sudden cardiac death: an important focus on a multidisciplinary approach to a tailored diagnostic and therapeutic work-up|Linee guida europee 2022 su aritmie ventricolari e morte cardiaca improvvisa: un importante impulso a un impegno multidisciplinare in campo diagnostico e terapeutico per un’accurata personalizzazione dell’approccio clinico 260
Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry 246
Long-term outcomes of postoperative atrial fibrillation following non cardiac surgery: A systematic review and metanalysis 242
Comparative analysis of level of evidence and class of recommendation for 50 clinical practice guidelines released by the European Society of Cardiology from 2011 to 2022 229
Atrial cardiomyopathy: An entity of emerging interest in the clinical setting 228
Red blood cell distribution width in patients undergoing transcatheter aortic valve implantation: Implications for outcomes 223
Atrial fibrillation burden: Stepping beyond the categorical characterization 221
Progression of Atrial Fibrillation after Cryoablation 220
Red cell distribution width: a routinely available biomarker with important clinical implications in patients with atrial fibrillation 215
Atrial fibrillation pattern and factors affecting the progression to permanent atrial fibrillation 214
Detection of subclinical atrial fibrillation with cardiac implanted electronic devices: What decision making on anticoagulation after the NOAH and ARTESiA trials? 209
The Euro Heart Survey and EURObservational Research Programme (EORP) in atrial fibrillation registries: contribution to epidemiology, clinical management and therapy of atrial fibrillation patients over the last 20 years 209
Usefulness of Red Cells Distribution Width to Predict Worse Outcomes in Patients With Atrial Fibrillation 206
What do we do about atrial high rate episodes? 206
Short and long-term outcomes after cardiac surgery in Jehovah's Witnesses patients: a case-control study 205
A systematic review and meta-analysis on oncological radiotherapy in patients with a cardiac implantable electronic device: Prevalence and predictors of device malfunction in 3121 patients 205
Radiotherapy-induced malfunctions of cardiac implantable electronic devices in cancer patients 204
Single-lead VDD pacing: a literature review on short-term and long-term performance 203
Atrial fibrillation and remote monitoring through cardiac implantable electronic devices in heart failure patients 203
Low Occurrence of Infections and Death in a Real-World Cohort of Patients with Cardiac Implantable Electronic Devices 202
Beyond the 2020 guidelines on atrial fibrillation of the European society of cardiology 201
Impact of body mass index on the outcome of elderly patients treated with transcatheter aortic valve implantation 201
Atrial Fibrillation and the Risk of Early‐Onset Dementia: A Systematic Review and Meta‐Analysis 196
Antithrombotic treatment in atrial fibrillation patients undergoing percutaneous coronary interventions: focus on stent thrombosis 194
Cognitive impairment in patients with atrial fibrillation: Implications for outcome in a cohort study 193
Atrial fibrillation before and after transcatheter aortic valve implantation: short- and long-term clinical implications 192
Female sex and stroke in atrial fibrillation: an intriguing relationship 192
Atrial fibrillation in patients with cardiac implantable electronic devices: New perspectives with important clinical implications 191
Atrial high-rate episodes: clinical significance, prognostic impact and clinical management 191
Atrial Fibrillation and Other Cardiovascular Factors and the Risk of Dementia: An Italian Case–Control Study 187
Three-Dimensional Automated, Machine-Learning-Based Left Heart Chamber Metrics: Associations with Prevalent Vascular Risk Factors and Cardiovascular Diseases 187
Technical Suitability of Implantable Cardiac Devices for Recreational Diving 184
Managing atrial fibrillation: the need for an individualized approach even in the emergency department 183
Adherence to the “Atrial fibrillation Better Care” (ABC) pathway in patients with atrial fibrillation and cancer: A report from the ESC-EHRA EURObservational Research Programme in atrial fibrillation (EORP-AF) General Long-Term Registry 181
Cardiac Surgery in Jehovah's Witnesses Patients and Association With Peri-Operative Outcomes: A Systematic Review and Meta-Analysis 181
Clinical Factors Associated with Atrial Fibrillation Detection on Single-Time Point Screening Using a Hand-Held Single-Lead ECG Device 181
Anticoagulation to prevent ischemic stroke in patients with atrial fibrillation: a complex scenario including underdiagnosis, undertreatment or underdosing of oral anticoagulants 176
Optimizing indices of atrial fibrillation susceptibility and burden to evaluate atrial fibrillation severity, risk and outcomes 176
Cardiovascular Reasons for Access to a Tertiary Oncological Emergency Service: The CARILLON Study 175
Atrial fibrillation in pneumonia: what clinical implications at long-term? 175
Factors Associated with Progression of Atrial Fibrillation and Impact on All-Cause Mortality in a Cohort of European Patients 174
Permanent Atrial Fibrillation as the Terminal Stage of a Chronic Disease: Palliative Care Needs to be Considered in Selected Patients with Markedly Impaired Quality of Life 174
Clinical phenotype classification of atrial fibrillation patients using cluster analysis and associations with trial-adjudicated outcomes 173
Cardiac resynchronization therapy (CRT) nonresponders in the contemporary era: A state-of-the-art review 171
Features of Clinical Complexity in European Patients With Atrial Fibrillation: A Report From a European Observational Prospective AF Registry 170
Atrial cardiomyopathy: a derangement in atrial volumes, geometry, function, and pathology with important clinical implications 170
Atrial fibrillation screening: Great debate on which approach to apply, which tools to use and which population to target 167
Association of comorbidity patterns with outcomes and relation with the ABC pathway effectiveness in European patients with atrial fibrillation 167
Ventricular and Atrial Remodeling after Transcatheter Edge-to-Edge Repair: A Pilot Study 166
Prevalence, management and impact of chronic obstructive pulmonary disease in atrial fibrillation: a systematic review and meta-analysis of 4,200,000 patients 165
Burden of disease and costs of infections associated with cardiac implantable electronic devices 165
Grey zones in the practice of permanent cardiac pacing: The case of preventive pacing for improving rhythm control in atrial fibrillation 163
Systematic review and meta-Analysis on the impact on outcomes of device algorithms for minimizing right ventricular pacing 161
Atrial fibrillation in vascular surgery: a systematic review and meta-analysis on prevalence, incidence and outcome implications 161
Anthropometric parameters and radiation doses during percutaneous coronary procedures 161
Performance of HAS-BLED and DOAC scores to predict major bleeding events in atrial fibrillation patients treated with direct oral anticoagulants: A report from a prospective European observational registry 161
Biomarkers in atrial fibrillation: A constant search for simplicity, practicality, and cost-effectiveness 158
Remote multiparametric monitoring and management of heart failure patients through cardiac implantable electronic devices 156
Comparing atrial fibrillation guidelines: Focus on stroke prevention, bleeding risk assessment and oral anticoagulant recommendations 156
Quantification of Myocardial Contraction Fraction with Three-Dimensional Automated, Machine-Learning-Based Left-Heart-Chamber Metrics: Diagnostic Utility in Hypertrophic Phenotypes and Normal Ejection Fraction 155
Clinical decisions for appropriate management of patients with atrial fibrillation 155
Comparing outcomes in asymptomatic and symptomatic atrial fibrillation: A systematic review and meta-analysis of 81,462 patients 155
Cardiac resynchronization therapy: variations across Europe in implant rates and types of implanted devices 152
COVID-19 pandemic: complex interactions with the arrhythmic profile and the clinical course of patients with cardiovascular disease 151
Cardiac resynchronization therapy: Need to synchronize patients and device longevities with comorbidities 149
From meta-analysis to the individual patient with atrial fibrillation and coronary artery disease: the complexity of antithrombotic treatment in real-world clinical practice and the need for a tailored approach 148
Epidemiology and impact of frailty in patients with atrial fibrillation in Europe 147
Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Research Programme in AF (EORP-AF) General Long-Term Registry 146
GESTIONE CLINICA, COMORBIDITÀ ED EVENTI AVVERSI ASSOCIATI IN PAZIENTI CON FIBRILLAZIONE ATRIALE: ANALISI DA UNO STUDIO DI COORTE EUROPEO SU OLTRE 11.000 PAZIENTI 145
Rhythm- or rate-control strategies according to 4S-AF characterization scheme and long-term outcomes in atrial fibrillation patients: the FAMo (Fibrillazione Atriale in Modena) cohort 144
Implantable cardioverter defibrillators and devices for cardiac resynchronization therapy: what perspective for patients’ apps combined with remote monitoring? 144
Atrial fibrillation and HIV: a new association requiring pathophysiological and outcome studies 142
Digital literacy as a potential barrier to implementation of cardiology tele-visits after COVID-19 pandemic: The INFO-COVID survey 142
Driving restriction in patients with cardiac implantable electronic devices: an overview of worldwide regulations 138
Tailored oral anticoagulant prescription in patients with atrial fibrillation: Use and misuse of clinical risk prediction scores 136
Comparison of HAS-BLED and ORBIT Bleeding Risk Scores in AF Patients treated with NOACs: A Report from the ESC-EHRA EORP-AF General Long-Term Registry 136
Real-world applicability and impact of early rhythm control for European patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF Long-Term General Registry 135
Cardiomyopathy associated with long-term right ventricular pacing: an intriguing clinical issue 132
Red cell distribution width and patient outcome in cardiovascular disease: A ‘’real-world” analysis 132
Atrial high rate episodes as a marker of atrial cardiomyopathy: In the quest of the Holy Grail. Author's reply 132
Yield of diagnosis and risk of stroke with screening strategies for atrial fibrillation: a comprehensive review of current evidence 131
Impact of anthropometric factors on outcomes in atrial fibrillation patients: analysis on 10 220 patients from the European Society of Cardiology (ESC)-European Heart Rhythm Association (EHRA) EurObservational Research Programme on Atrial Fibrillation (EORP-AF) general long-term registry 131
CHA2DS2-VA instead of CHA2DS2-VASc for stroke risk stratification in patients with atrial fibrillation: not just a matter of sex 130
Clinical Profile, Arrhythmias, and Adverse Cardiac Outcomes in Emery–Dreifuss Muscular Dystrophies: A Systematic Review of the Literature 130
Peripheral artery disease, antithrombotic treatment and outcomes in European and Asian patients with atrial fibrillation: analysis from two prospective observational registries 129
How did COVID-19 affect medical and cardiology journals? A pandemic in literature 129
The 12-lead ECG: A continuous reference for the cardiologist 128
The importance of adherence and persistence with oral anticoagulation treatment in patients with atrial fibrillation 127
Totale 19.076
Salva come PNG Salva come JPEG
Categoria #
all - tutte 115.001
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 115.001
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.092 0 80 20 38 39 102 30 57 128 99 244 255
2022/20231.454 155 154 119 69 125 175 49 149 206 44 130 79
2023/20241.648 52 86 107 170 283 238 123 213 38 51 87 200
2024/20255.807 131 91 299 364 991 780 546 346 564 414 618 663
2025/202610.736 744 437 901 1.119 1.060 600 1.624 573 1.180 938 890 670
2026/20271.564 453 1.111 0 0 0 0 0 0 0 0 0 0
Totale 23.519